Profile
Full Name
UroGen Pharma Ltd.Ticker Symbol
URGNExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
May 4, 2017Indexes
Not includedWebsite
http://www.urogen.comEmployees
234Key Details
Price
$13.49(+2.90%)
Market cap
$621.99M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$90.40M(+9.29% YoY)
Annual EPS
-$2.96(+16.62% YoY)
Next earnings date
Aug 13, 2025Next ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
UroGen Pharma doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Jun 13, 25 Scotiabank
Sector OutperformJun 13, 25 Guggenheim
BuyJun 12, 25 D. Boral Capital
BuyJun 3, 25 Oppenheimer
OutperformMay 23, 25 Guggenheim
BuyMay 22, 25 HC Wainwright & Co.
NeutralMay 22, 25 Goldman Sachs
NeutralMay 13, 25 HC Wainwright & Co.
BuyMay 12, 25 D. Boral Capital
BuyMay 8, 25 D. Boral Capital
BuyInstitutional Ownership
- What is the ticker symbol for UroGen Pharma?
- Does UroGen Pharma pay dividends?
- What sector is UroGen Pharma in?
- What industry is UroGen Pharma in?
- What country is UroGen Pharma based in?
- When did UroGen Pharma go public?
- Is UroGen Pharma in the S&P 500?
- Is UroGen Pharma in the NASDAQ 100?
- Is UroGen Pharma in the Dow Jones?
- When was UroGen Pharma's last earnings report?
- When does UroGen Pharma report earnings?
- Should I buy UroGen Pharma stock now?
What is the ticker symbol for UroGen Pharma?
The ticker symbol for UroGen Pharma is NASDAQ:URGN
Does UroGen Pharma pay dividends?
No, UroGen Pharma does not pay dividends
What sector is UroGen Pharma in?
UroGen Pharma is in the Healthcare sector
What industry is UroGen Pharma in?
UroGen Pharma is in the Biotechnology industry
What country is UroGen Pharma based in?
UroGen Pharma is headquartered in United States
When did UroGen Pharma go public?
UroGen Pharma's initial public offering (IPO) was on May 4, 2017
Is UroGen Pharma in the S&P 500?
No, UroGen Pharma is not included in the S&P 500 index
Is UroGen Pharma in the NASDAQ 100?
No, UroGen Pharma is not included in the NASDAQ 100 index
Is UroGen Pharma in the Dow Jones?
No, UroGen Pharma is not included in the Dow Jones index
When was UroGen Pharma's last earnings report?
UroGen Pharma's most recent earnings report was on May 12, 2025
When does UroGen Pharma report earnings?
The next expected earnings date for UroGen Pharma is Aug 13, 2025
Should I buy UroGen Pharma stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions